34.000USD+34.000After-hours 08/03, 20:00 (ET)
311.28MMarket Cap
LossP/E TTM
Key Figures
33.620Open
34.000High
576.55KVolume
LossP/E TTM
45.86P/E Dynamic
--Dividend TTM
6.29%Turnover Ratio
34.060Prev. Close
33.620Low
12.56MTurnover
LossP/E Static
44.15P/B
0.00%Div Yield TTM
0.75%ROA
35.95052wk High
0.67Volume Ratio
-9.66MNet Profit
9.17MShares
-3.8918EPS TTM
1.22Beta
2.89%ROE
16.04752wk Low
1.12%Amplitude
90.97%Gross Margin
311.28MMarket Cap
9.96Reward/Risk
3.55%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Sanara Medtech Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 73 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 34.33.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sanara Medtech Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Sanara Medtech Inc Highlights
StrengthsRisks
Sanara Medtech Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Sanara Medtech Inc Info
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Ticker SymbolSMTI
CompanySanara Medtech Inc
CEOMuppalla (Suresh V)
Websitehttps://sanaramedtech.com/
Shareholders
FAQs
What is the current price of Sanara Medtech Inc (SMTI)?
The current price of Sanara Medtech Inc (SMTI) is 33.86.
What is the symbol of Sanara Medtech Inc?
The ticker symbol of Sanara Medtech Inc is SMTI.
What is the 52-week high of Sanara Medtech Inc?
The 52-week high of Sanara Medtech Inc is 35.95.
What is the 52-week low of Sanara Medtech Inc?
The 52-week low of Sanara Medtech Inc is 16.05.
What is the market capitalization of Sanara Medtech Inc?
The market capitalization of Sanara Medtech Inc is 311.28M.
Is Sanara Medtech Inc (SMTI) currently rated as Buy, Hold, or Sell?
According to analysts, Sanara Medtech Inc (SMTI) has an overall rating of signal_hold, with a price target of 35.00.
What is the Earnings Per Share (EPS TTM) of Sanara Medtech Inc (SMTI)?
The Earnings Per Share (EPS TTM) of Sanara Medtech Inc (SMTI) is -4.36.